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BACKGROUND Transradial access (TRA) for percutaneous coronary
intervention (PCI) reduces complications compared to transfemoral
access (TFA). Elderly patients have a higher rate of complications and
adverse outcomes after PCI, yet only a few studies have compared the
outcomes between both approaches and results have been inconsis-
tent. We aimed to evaluate the efﬁcacy and safety between TRA and
TFA in elderly patients  75 year old undergoing PCI.
METHODS We conducted electronic literature search of PubMed CEN-
TRAL, EMBASE, The Cochrane Register of Controlled Trials, Google
Scholar databases and the scientiﬁc session abstracts. The primary ef-
ﬁcacy endpoint was major adverse cardiovascular events (MACE), all-
cause mortality, new myocardial infarction (MI), and length of stay.
Safety endpoints included vascular complications, major bleeding,
procedure failure, and target vessel revascularization (TVR). Odds ratios
(OR) and 95% conﬁdence intervals (CI) were computed using the
Mantel-Haenszel (MH) method. Fixed-effect model was used; if het-
erogeneity (I2)>40, effects were obtained using a random model.
RESULTS Ten studies were included, with a total of 4,235 patients.
There was a signiﬁcant difference favoring TRA for MACE [OR 0.7, 95%
CI 0.58-0.88; p <0.01] and length of stay [Standardized mean difference
0.16, CI 0.05-0.26, p <0.01] compare to TFA. Though there was a mar-
ginal effect towards TRA, no difference was seen for the incidence of
new MI [OR 0.94 95% CI 0.58-1.52; p 0.81] and all-cause mortality [OR
0.5, 95% CI 0.25-1.03; p 0.06] between both approaches. For safety
endpoints we found a signiﬁcant difference favoring TRA compared to
TFA for vascular complications [OR 0.33 95% CI 0.24-0.45; p<0.01] and
major bleeding [OR 0.29 85% CI 0.18-0.47; p<0.01]. No difference was
seen between TFA and TRA for procedure failure [OR 0.65 95% CI 0.39-
1.08; p 0.09] and TVR [OR 0.18 95% CI 0.01-3.1; p 0.24].
CONCLUSIONS Our meta-analysis showed that TRA is associated with
favorable outcomes and fewer complications compare to TFA. TRA
should be considered as a feasible and safe approach in the elderly
population undergoing PCI.
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BACKGROUND Compared to medical treatment, clinical beneﬁt of
percutaneous coronary intervention (PCI) has not been clearly estab-
lished in elderly patients with angina pectoris because of increased
risk of complications or adverse cardiac events after PCI in elderly
patients with higher incidence of multiple comorbidities and fragile
physical performance.
METHODS we evaluated the efﬁcacy of elective PCI versus optimal
medical treatment (OMT) in elderly patients (age between 75 and 84
years old) with angina pectoris. One-hundred seventy-seven patients
with signiﬁcant coronary artery stenosis were randomly assigned into
either the PCI group (n¼90) or the OMT group (n¼87). The primary
outcome was a composite of major adverse events which consisted of
cardiovascular death, nonfatal myocardial infarction, coronary
revascularization or stroke for 1 year follow-up.
RESULTS Major adverse events occurred in 5 patients (5.6%) of the
PCI group and 17 patents (19.5%) of the OMT group (p¼0.015). There
were no signiﬁcant differences between the PCI group and the OMT
group in cardiac death [hazard ratio (HR) for the PCI group 0.454; 95%
conﬁdence interval (CI), 0.041-5.019, p¼0.520], myocardial infarction
(HR 0.399; 95% CI, 0.039-4.050, p¼0.437) and stroke (HR 0.919; 95%
CI 0.057-14.709, p¼0.952). However, the PCI group showed preventive
effect for the coronary revascularization (HR 0.157; 95% CI 0.035-
0.703, p¼0.016) and a composite of major adverse events (HR 0.288;
95% CI 0.106-0.785, p¼0.015).
CONCLUSIONS In conclusion, compared to OMT, elective PCI reduced
major adverse events and is an effective treatment modality in elderly
patients with angina pectoris and signiﬁcant coronary artery stenosis.
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BACKGROUND The economic and human burden of Coronary Artery
Disease (CAD) is substantial. Although Percutaneous Coronary Inter-
vention (PCI) can reduce the morbidity and mortality associated with
CAD, recent clinical trial data indicate that up to a third of patients
experience angina in the year after PCI. Given the selective inclusion
criteria of most trials, results cannot always be extrapolated to all
patients treated. This study aimed to use real-world data to explore
the incidence of post PCI angina and chest pain and subsequent costs
to secondary care providers in England.
METHODS Hospital Episode Statistic (HES) data were used to iden-
tify adults who had undergone PCI between March 1st 2011 –
December 31st 2011 (index event) in England. Patients with 3 years of
post-index event data were included in the analysis. Clinically sig-
niﬁcant outcomes were deﬁned as presentation to hospital de-
partments with angina and chest pain. Patients were identiﬁed from
data extracted from HES for inpatient admissions, outpatient con-
sultations and accident and emergency visits associated with rele-
vant World Health Organisation International Disease Codes (WHO
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post PCI angina and chest pain were conducted using Payment by
Results coding in the HES data set. Cost estimates were presented in
2013/14 prices based on the Hospital and Community Health Services
index (HCHS).
RESULTS 32,492 met study inclusion criteria (mean age 64 years
[SD 11.8], 74% male). The cumulative incidence of angina/chest pain
was 23% (n¼ 7,473) at 12 months, 31% (n¼ 10,199) at 24 months and
37% (n¼ 11,940) at 36 months following PCI. It is estimated that
bootstrapped cumulative mean costs to the secondary care provider
were signiﬁcantly higher at 12 months in those with angina/chest
pain at £ 10,215, 95% CI [£10,083, £10,348] vs. £6,552, 95% CI
[£6,503, £6,601] for those without. Signiﬁcant cost differences per-
sisted to 36 months post PCI £ 14,754 95% CI [£14,571 £14,936] for
those with angina vs. £ 8,407, 95% CI [£8,324, £8,489] for those
without.
CONCLUSIONS Our analysis, using real-world data, suggests that
angina and chest pain are common following PCI. Moreover, incidence
increased over time, to the extent that at 36 months over a third of
patients experienced angina/chest pain. This is important because
angina and chest pain have a detrimental impact on patients health
related quality of life. In addition our analysis indicates that resource
consumption is considerably greater in those affected. As angina/
chest pain following PCI are associated with a human and economic
burden, therapeutic strategies, or interventions resulting in a lower
incidence of angina and chest pain post PCI, would have the potential
to reduce the ﬁnancial burden on the NHS.
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BACKGROUND Long-term health-related-quality-of-life (HRQoL)
beneﬁts of percutaneous coronary intervention (PCI) for chronic total
occlusions (CTO) are not well established.
METHODS Consecutive patients undergoing PCI at our institution
from September 2009 to January 2011 were evaluated. EuroQoL-5D
(EQ-5D) health survey was used to assess HRQoL at baseline, 6- 12-, 24
and 36-months. Utility score improvement of 0.11 was considered
minimal clinically important difference (MCID). Changes in quality-
adjusted-life-years (QALY) were compared between patients who
underwent successful single-vessel CTO (S-CTO) with failed CTO (F-
CTO) and successful non-CTO lesion.
RESULTS Of 453 patients who underwent single-vessel PCI, 10.6%
(n¼48) were CTO and 89.4% (n¼405) were non-CTO lesions. PCI was
successful in 72.9% (n¼35/48) CTOs and 98.8% (n¼400/405) non-CTO.
Mean utility scores improved after S-CTO from 0.670.20 to
0.850.16 at 36-months, 0.560.23 to 0.850.16 after S-NCTO and
0.690.17 to 0.890.12 after F-CTO (all p<0.01). 3-year QALY gained
was highest after S-NCTO (0.820.79) compared to S-CTO (0.530.75)
and F-CTO (0.470.76, p<0.01). Baseline utility score was inversely
proportional to QALY gained after S-CTO where the lowest baseline
utility score quartile (<0.47) had the largest QALY gain (1.69)
compared to the highest quartile (>0.71) with the smallest gain (0.16,
p<0.01). Proportion of patients who experienced MCID improvement
at 36-months was lower after S-CTO (64.0%) compared with S-NCTO
(82.6%).
CONCLUSIONS Successful CTO PCI was associated with modest long-
term HRQoL improvement which was signiﬁcantly less than after non-
CTO intervention. About forty percent of patients did not achieve
minimal clinically important improvement in HRQoL 36-month after
successful CTO PCI. High baseline health status was associated with
minimal QALY gain after CTO intervention. Further studies are war-
ranted to identify which CTO patients are most likely to beneﬁt after
PCI.
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BACKGROUND Several clinical and pathological studies have sug-
gested an association between incomplete stent apposition (ISA) and
delayed neointimal healing and adverse events (stent thrombo-
sis).The aim of this study was to evaluate the impact of strut appo-
sition and stent design on progression of stent strut neointimal
coverage.
METHODS To evaluate the impact of ISA on the progression of neo-
intimal coverage, we developed an in-vivo model of ISA and studied
follow-up response and coverage characteristics of well-apposed and
malapposed segments for a series of Drug Eluting Stents (DES)
(Cypher, PROMUS Element and Orsiro) and Bioresorbable Vascular
Scaffolds (ABSORB BVS). Optical Coherence Tomography (OCT) was
sequentially performed at baseline, 1 week and 4 weeks of follow-up.
In addition, evidences were provided by histological analysis per-
formed at 4 weeks follow-up and Computer Fluid Dynamic (CFD)
simulations describing the shear stress characteristics around apposed
versus non-apposed struts.
RESULTS A total of 325 cross sections and 3166 struts were analyzed.
After implantation, stents had an average of 16.1% of struts that were
malapposed or non-apposed side branch (NASB). Malapposition extent
decreased over time as a result of neointimal healing (from 10.9% at
baseline to 0% at 4 weeks; p ¼ 0.03). At 1 week, 8.5% of struts in well
apposed segments were still uncovered versus 14.5% of struts in mal-
apposed cross-sections and 66.7% of NASB struts (p < 0.0001). At 4
weeks follow up, 0% of struts were uncovered in well apposed cross-
sections vs. 0.4% inmalapposed cross-sections and 50% of NASB struts
(p< 0.0001). Comparison of the impact of stent design onwell-apposed
segments revealed that thin strut Orsiro had only 1.1% of uncovered
struts at 1 week while Promus Element, Cypher and BVS had 7%, 48.4%
and 18.2% of struts still uncovered respectively (p < 0.0001).
CONCLUSIONS This study shows that early coverage is inﬂuenced by
stent apposition as well as platform strut characteristics. At 4 weeks,
only NASB struts remained a focus of delayed re-endothelialization.
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